Market Place
Sourcing Support
Former Immunomedics CFO pleads guilty to securities fraud
18 May 2023 //
FIERCE BIOTECH
Girlfriend of ex-Immunomedics CFO pleads guilty to fraud
24 Jun 2022 //
ENDPTS
Immunomedics`s Trodelvy (Sacituzumab Govitecan) Receives Approval the U.S.
03 Jun 2022 //
FDA
Former Immunomedics CFO indicted on insider trading charges
12 May 2022 //
FIERCEBIOTECH
Immunomedics will settle claims it misrepresented Trodelvy data
19 Apr 2022 //
FIERCEPHARMA
Gilead Sciences will lay off 114 staffers in NJ
10 Mar 2022 //
FIERCEPHARMA
Ex-Immunomedics CFO Malik charged with insider trading
03 Dec 2021 //
FIERCEBIOTECH
Gilead`s Immunomedics CMO exits to Aadi as it nears FDA decision
26 Oct 2021 //
FIERCEBIOTECH
Ex-Immunomedics CEO takes the wheel at Danish ADC player
07 Jul 2021 //
FIERCEBIOTECH
Gilead wins full approval for drug acquired in Immunomedics deal
09 Apr 2021 //
BIOPHARMADIVE
A diagnostics company completes its pharma makeover, rebranding as Fore
22 Feb 2021 //
ENDPTS
Immunome’s Research Reveals a Broad Super Responder Memory B Cell Response
01 Feb 2021 //
BUSINESSWIRE
Gilead completes $21B buyout of Immunomedics; Innate receives $50M milestone
24 Oct 2020 //
ENDPTS
Gilead Sciences Completes Acquisition of Immunomedics, Inc.
22 Oct 2020 //
BUSINESSWIRE
US FDA grants orphan drug status to Immunomedics’ Trodelvy to treat glioblastoma
13 Oct 2020 //
PHARMABIZ
Immunomedics Announces FDA Orphan Drug Designation of Trodelvy™
12 Oct 2020 //
GLOBENEWSWIRE
Gilead`s $21B Immunomedics buyout mints a new biotech billionaire
26 Sep 2020 //
ENDPTS
Did Gilead overpay for Immunomedics? Trodelvy answered the question
25 Sep 2020 //
FIERCE PHARMA
Gilead Sciences Prices $7.25 Billion of Senior Unsecured Notes
23 Sep 2020 //
BUSINESSWIRE
Trodelvy breast, bladder cancer data show Gilead`s going big for Immunomedics
21 Sep 2020 //
FIERCE PHARMA
Immunomedics Announces Trodelvy™ Significant OS In PhIII Ascent Study
20 Sep 2020 //
GLOBENEWSWIRE
Immunomedics Announces Positive Results From Pivotal PhII Trial Of Trodelvy™
20 Sep 2020 //
GLOBENEWSWIRE
Immunomedic`s Trodelvy™ Encouraging Early-Stage Clinical Results
19 Sep 2020 //
PRESS RELEASE
Mersana Therapeutics: Poised To Capitalize As Billions Pour Into ADCs
16 Sep 2020 //
SEEKING ALPHA
Gilead needs `heroic` Immunomedics revenues to get a return on $21B deal
15 Sep 2020 //
FIERCE PHARMA
Gilead to buy cancer drugmaker Immunomedics for $21 billion
14 Sep 2020 //
REUTERS
Immunomedics announces US FDA approval of Samsung Biologics
18 Aug 2020 //
PHARMABIZ
Immunomedics Announces FDA Approval of Samsung as Antibody MFG Trodelvy™
17 Aug 2020 //
GLOBENEWSWIRE
New York Medical College, Touro College and University System receives US patent
14 Jul 2020 //
PHARMABIZ
Immunomedics Expands Collaboration with Roche Evaluating Trodelvy™
13 Jul 2020 //
GLOBENEWSWIRE
Immunomedics phase 3 ASCENT study of Trodelvy to treat mTNBC meets endpoints
07 Jul 2020 //
PHARMABIZ
Immunomedics’ breast cancer drug delays tumor growth, prolongs survival
06 Jul 2020 //
STATNEWS
Immunomedics CEO Semerjian out of top post—Chutes & Ladders
29 May 2020 //
FIERCEBIOTECH
Immunomedics` 1-month CEO hits COVID-19 exit, $1M in hand
28 May 2020 //
FIERCE PHARMA
Immunomedics Announces Leadership Change and Provides Business Update
27 May 2020 //
GLOBENEWSWIRE
Stymied by the pandemic, Immunomedics` new CEO bows out, taking a million
27 May 2020 //
ENDPTS
Immunomedics Announces Commercial Availability of TRODELVY™ in the United States
04 May 2020 //
GLOBENEWSWIRE
Immunomedics Announces Closing Of Public Offering Of Common Stock
01 May 2020 //
GLOBENEWSWIRE
Everest Medicines Announces That Licensing Partner Immunomedics for Trodelvy
27 Apr 2020 //
GLOBENEWSWIRE
Immunomedics taps Ipsen exec Semerjian as CEO—Chutes & Ladders
10 Apr 2020 //
FIERCE BIOTECH
Immunomedics stops Phase III breast cancer study early
07 Apr 2020 //
CLINICALTRIALSARENA
FDA issues form 483 to Immunomedics Inc
03 Apr 2020 //
FDA
Immunomedics nabs J&J veteran for CMO
15 Feb 2020 //
FIERCE BIOTECH
After FDA rejection, Immunomedics tries again with breast cancer drug
04 Dec 2019 //
BIOPHARMA DIVE
Immunome teams up with pH Pharma in cancer; shares up 2%
21 Oct 2019 //
SEEKINGAPPHA
Seattle Genetics` armed antibody scores high in frontline bladder cancer
28 Sep 2019 //
ENDPTS
CMO walks out on troubled Immunomedics—Chutes & Ladders
03 May 2019 //
FIERCE BIOTECH
Iannone walks out on troubled Immunomedics
30 Apr 2019 //
FIERCE BIOTECH
FDA Issues EIR to Immunomedics
30 Apr 2019 //
FDA
Immunomedics could face longer lead drug delay as CEO quits
26 Feb 2019 //
FIERCE BIOTECH
Immunomedics CEO Michael Pehl hits the exit on the heels of a CRL
26 Feb 2019 //
ENDPTS
Immunomedics Receives FDA Form 483
20 Feb 2019 //
FDA
Immunomedics Receives FDA Form 483
13 Feb 2019 //
FDA
US regulator wipes the smile off Immunomedics’ face
19 Jan 2019 //
EVALUATE PHARMA
